PHK
CERE

Point72 Hong Kong’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Point72 Hong Kong’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,470
Closed -$42K – 1794
2022
Q3 		$42K Buy
+1,470
New +$43.8K ﹤0.01% 1467
2022
Q1 		– Sell
-4,702
Closed -$152K – 2448
2021
Q4 		$152K Sell
4,702
-3,814
-45% -$135K 0.01% 1078
2021
Q3 		$251K Buy
+8,516
New +$239K 0.01% 1117

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Hong Kong's CERE Position: Q4 2022 in Review

Point72 Hong Kong sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q4 2022, closing a stake of 1,470 shares — an estimated $42K sold.

Point72 Hong Kong first reported a position in CERE in Q3 2021 and held it in 3 quarters. The position peaked at $251K in Q3 2021. 125 funds tracked by Wall St. Rank hold CERE as of Q4 2022.

  • Point72 Hong Kong reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,470 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $42K.
  • Point72 Hong Kong first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $251K in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.